Oscar Health, Inc. (OSCR) shares plummeted 21.47% in Tuesday's after-hours trading session after the health insurer reported worse-than-expected fourth quarter earnings results and provided underwhelming full-year 2025 revenue guidance.
For the fourth quarter, Oscar Health posted an earnings per share loss of $0.62, wider than the consensus analyst estimate of $0.58 per share. Revenue for the quarter came in at $2.39 billion, missing expectations of $2.47 billion. The company cited higher medical costs as a key factor behind the earnings miss.
Looking ahead, Oscar Health's full-year 2025 revenue guidance of $11.2-11.3 billion fell short of the consensus estimate of $11.69 billion, raising concerns among investors about the company's growth prospects. The disappointing guidance overshadowed the company's forecast for a return to profitability in 2025, with expected earnings from operations between $225-275 million.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。